Absolute Quantification and Differential Expression of Drug Transporters, Cytochrome P450 Enzymes, and UDP-Glucuronosyltransferases in Cultured Primary Human Hepatocytes

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Drug Metabolism And Disposition

• Publication date

  2012-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/dmd.111.042275PMID 21979928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities

  2012cited by this paper
• Reliability and robustness of simultaneous absolute quantification of drug transporters, cytochrome P450 enzymes, and Udp-glucuronosyltransferases in human liver tissue by multiplexed MRM/selected reaction monitoring mode tandem mass spectrometry with nano-liquid chromatography.

  2011cited by this paper
• Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects.

  2011cited by this paper
• Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection.

  2011cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Cytochrome P450 3A4 mRNA Is a More Reliable Marker than CYP3A4 Activity for Detecting Pregnane X Receptor-Activated Induction of Drug-Metabolizing Enzymes

  2010cited by this paper
• Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery.

  2010cited by this paper
• Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity

  2010cited by this paper
• In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective

  2009cited by this paper
• Current trends in quantitative proteomics.

  2009cited by this paper
• Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 induction.

  2009cited by this paper
• Current Industrial Practices in Assessing CYP450 Enzyme Induction: Preclinical and Clinical

  2008cited by this paper
• Efficient assessment of the utility of immortalized Fa2N-4 cells for cytochrome P450 (CYP) induction studies using multiplex quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and substrate cassette methodologies

  2008cited by this paper
• Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria

  2008cited by this paper
• Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.

  2008cited by this paper
• Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro–in vivo correlations

  2007cited by this paper
• EVALUATION OF TIME-DEPENDENT CYTOCHROME P450 INHIBITION USING CULTURED HUMAN HEPATOCYTES

  2006cited by this paper
• GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS

  2006cited by this paper
• Transporters as a determinant of drug clearance and tissue distribution.

  2006cited by this paper
• Isolation and culture of primary human hepatocytes.

  2005cited by this paper
• Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards.

  2003cited by this paper
• Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes.

  2003cited by this paper
• CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes.

  2002cited by this paper
• Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation.

  2001influential reference
• Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor.

  2001cited by this paper
• In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone

  2000influential reference
• Ritonavir

  1998cited by this paper
• Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration.

  1994cited by this paper

• Transporter-transporter interplay determines the renal-predominant elimination of the O-glucuronide metabolite (BI 689875) of vicadrostat in humans.

  2025cites this paper
• Influence of 3-dimensional architecture and coculture on in vitro CYP enzyme metabolism and induction: Benchmarking human hepatic spheroids for studies in drug development.

  2025cites this paper
• Beyond Michaelis-Menten: A Modified Enzyme Kinetics Equation Improves Drug Metabolism Prediction in Bottom-Up PBPK Modeling.

  2025cites this paper
• A three-dimensional (3D) liver-kidney on a chip with a biomimicking circulating system for drug safety evaluation.

  2024cites this paper
• Lack of CYP3A4 protein induction despite mRNA induction in primary hepatocytes exposed to rifabutin as a possible explanation for its low interaction risk in vivo

  2024cites this paper
• Application of transporter assays for drug discovery and development: an update of the literature

  2024cites this paper
• In vitro mechanistic study on mycophenolate mofetil drug interactions: effect of prednisone, cyclosporine, and others

  2024cites this paper
• Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-Matrigel matrices

  2023influential citation
• Fifty Years of Aryl Hydrocarbon Receptor Research as Reflected in the Pages of Drug Metabolism and Disposition

  2023cites this paper
• Special Section on Perspective on Drug Metabolism and Disposition, Part I — Minireview Fifty Years of Aryl Hydrocarbon Receptor Research as Reflected in the Pages of Drug Metabolism and Disposition

  2023cites this paper
• Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine

  2022cites this paper
• Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes

  2022cites this paper
• Human Hepatic Transporter Signature Peptides for Quantitative Targeted Absolute Proteomics: Selection, Digestion Efficiency, and Peptide Stability

  2022cites this paper
• Liver organ-on-chip models for toxicity studies and risk assessment.

  2022cites this paper
• Mass spectrometry-based targeted proteomics method for the quantification of clinically relevant drug metabolizing enzymes in human specimens.

  2021cites this paper
• Determination of CYP450 Expression Levels in the Human Small Intestine by Mass Spectrometry-Based Targeted Proteomics

  2021cites this paper
• Pregnancy-Related Hormones Increase UGT1A1-Mediated Labetalol Metabolism in Human Hepatocytes

  2021cites this paper
• Ultrasensitive quantification of drug-metabolizing enzymes and transporters in small sample volume by microflow LC-MS/MS.

  2021cites this paper
• Function and Expression of Bile Salt Export Pump in Suspension Human Hepatocytes

  2021cites this paper
• Application of proteomic data in the translation of in vitro observations to associated clinical outcomes.

  2021cites this paper
• Site-specific protein modification by 3-n-butylphthalide in primary hepatocytes: Covalent protein adducts diminished by glutathione and N-acetylcysteine.

  2021cites this paper
• The Expression Profiles and Deregulation of UDP-Glycosyltransferase (UGT) Genes in Human Cancers and Their Association with Clinical Outcomes

  2021cites this paper
• Proteomic evaluation of plasma membrane fraction prepared from mouse liver and kidney using a bead homogenizer: Enrichment of drug-related transporter proteins.

  2020cites this paper
• Quantitative and targeted proteomics-based identification and validation of drug efficacy biomarkers.

  2020cites this paper
• Prediction of Transporter-Mediated Drug-Drug Interactions and Phenotyping of Hepatobiliary Transporters Involved in the Clearance of E7766, a Novel Macrocycle-Bridged Dinucleotide

  2020influential citation
• Quantitative analysis of mRNA expression levels of aldo-keto reductase and short-chain dehydrogenase/reductase isoforms in human livers.

  2020cites this paper
• Circadian Clock–Controlled Drug Metabolism: Implications for Chronotherapeutics

  2020cites this paper
• A Comparison of Total and Plasma Membrane Abundance of Transporters in Suspended, Plated, Sandwich-Cultured Human Hepatocytes Versus Human Liver Tissue Using Quantitative Targeted Proteomics and Cell Surface Biotinylation

  2019cites this paper
• Mechanisms of CYP3A Induction During Pregnancy: Studies in HepaRG Cells

  2019cites this paper
• Induction of Human Intestinal and Hepatic Organic Anion Transporting Polypeptides: Where Is the Evidence for Its Relevance in Drug-Drug Interactions?

  2019cites this paper
• Development and validation of an absolute protein assay for the simultaneous quantification of fourteen CYP450s in human microsomes by HPLC-MS/MS-based targeted proteomics.

  2019cites this paper
• Probe Cocktail to Assess Transporter Function in Sandwich-Cultured Human Hepatocytes.

  2019cites this paper
• Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte model.

  2019influential citation
• Comparison of LC-MS/MS-based targeted proteomics and conventional analytical methods for monitoring breast cancer resistance protein expression.

  2019cites this paper
• Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: Applications in translational pharmacology and recommendations for best practice.

  2019cites this paper
• The UGTome: the expanding diversity of UDP glycosyltransferases and its impact on small molecule metabolism.

  2019cites this paper
• The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms.

  2019cites this paper
• Quantitative Expression of Hepatobiliary Transporters and Functional Uptake of Substrates in Hepatic Two-Dimensional Sandwich Cultures: A Comparative Evaluation of Upcyte and Primary Human Hepatocytes

  2018influential citation
• Impact of Promoter Polymorphisms on the Transcriptional Regulation of the Organic Cation Transporter OCT1 (SLC22A1)

  2018cites this paper
• Peptide-Based Sandwich Immunoassay for the Quantification of the Membrane Transporter Multidrug Resistance Protein 1.

  2018cites this paper
• Quantification of Hepatic Organic Anion Transport Proteins OAT2 and OAT7 in Human Liver Tissue and Primary Hepatocytes.

  2018cites this paper
• Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes

  2018cites this paper
• In vitro studies with two human organic anion transporters: OAT2 and OAT7

  2018cites this paper
• Direct Quantification of Cytochromes P450 and Drug Transporters—A Rapid, Targeted Mass Spectrometry-Based Immunoassay Panel for Tissues and Cell Culture Lysates

  2018influential citation
• Characterization of drug disposition in humans using novel in vitro methodologies based on the Extended Clearance Model

  2017influential citation
• Concept: The Use of Targeted Immunoaffinity Proteomics for Routine Assessment of In Vitro Enzyme Induction.

  2017cites this paper
• High-Throughput and Reliable Isotope Label-free Approach for Profiling 24 Metabolic Enzymes in FVB Mice and Sex Differences

  2017cites this paper
• Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes: Comparison of Two Proteomic Methods and Correlation with Catalytic Activity

  2017cites this paper
• LC-MS/MS quantification of sulfotransferases is better than conventional immunogenic methods in determining human liver SULT activities: implication in precision medicine

  2017cites this paper
• Glutathione S-transferase A1 (GSTA1) as a marker of acetaminophen-induced hepatocyte injury in vitro

  2017cites this paper
• From the Viewpoint of Drug Metabolism Research.

  2017cites this paper
• Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver

  2017cites this paper
• Effects of diosmetin on nine cytochrome P450 isoforms, UGTs and three drug transporters in vitro

  2017cites this paper
• Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP

  2017cites this paper
• Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing Enzymes

  2017cites this paper
• LC-MS/MS Based Quantitation of ABC and SLC Transporter Proteins in Plasma Membranes of Cultured Primary Human Retinal Pigment Epithelium Cells and Immortalized ARPE19 Cell Line.

  2017cites this paper
• Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions—an Industry Perspective

  2016cites this paper
• Upcyte Human Hepatocytes: a Potent In Vitro Tool for the Prediction of Hepatic Clearance of Metabolically Stable Compounds

  2016cites this paper
• Special Section on Emerging Novel Enzyme Pathways in Drug Metabolism — Commentary Cytochrome P 450 and Non – Cytochrome P 450 Oxidative Metabolism : Contributions to the Pharmacokinetics , Safety , and Efficacy of Xenobiotics

  2016cites this paper
• Ontogeny of Hepatic Drug Transporters as Quantified by LC‐MS/MS Proteomics

  2016cites this paper
• The omic approach to parasitic trematode research—a review of techniques and developments within the past 5 years

  2016cites this paper
• Liver and Kidney on Chips: Microphysiological Models to Understand Transporter Function

  2016cites this paper
• Subcellular fractionation of human liver reveals limits in global proteomic quantification from isolated fractions.

  2016cites this paper
• To attach or not to attach : factors behind variable adhesion properties of cryopreserved human hepatocytes

  2016cites this paper
• Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay Design.

  2016cites this paper
• Hepatoprotective effects of Solanum nigrum against ethanol‐induced injury in primary hepatocytes and mice with analysis of glutathione S‐transferase A1

  2016cites this paper
• Cytochrome P450 and Non–Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics

  2016cites this paper
• Microfabricated Devices for Studying the Metabolism and Cytotoxicity of Drug Candidates.

  2016cites this paper
• Development of a Liver-Kidney Dual Organ Microphysiological System for Predicting Organ-Organ Interactions in the Toxicity of Xenobiotics: Aristolochic Acid Nephrotoxicity as a proof of Principle

  2016cites this paper
• CYP2D6 Is Inducible by Endogenous and Exogenous Corticosteroids.

  2016cites this paper
• Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients

  2015cites this paper
• Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines

  2015cites this paper
• Towards a fully mechanistic prediction of oral drug absorption: Investigating intestinal transporter abundance and function relationships

  2015cites this paper
• Analysis of Sinusoidal Drug Uptake Transporter Activities in Primary Human Hepatocytes.

  2015cites this paper
• Polarized location of SLC and ABC drug transporters in monolayer-cultured human hepatocytes.

  2015cites this paper
• The role of membrane transporters in the pharmacokinetics of psychotropic drugs: in vitro studies with special focus on organic cation transporters

  2015influential citation
• Investigation of the impact of MRP3 and MRP4 on the disposition of drugs and conjugates in rat and human

  2015cites this paper
• Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometry

  2015cites this paper
• Quantification of proteins by flow cytometry: Quantification of human hepatic transporter P-gp and OATP1B1 using flow cytometry and mass spectrometry.

  2015cites this paper
• Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication

  2015cites this paper
• Quantitative Structure-Pharmacokinetic Relationships for the Prediction of Renal Clearance in Humans

  2015cites this paper
• A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development.

  2015cites this paper
• Multidimensional LC–MS/MS analysis of liver proteins in rat, mouse and human microsomal and S9 fractions

  2015cites this paper
• Primary Hepatocytes in Sandwich Culture.

  2015cites this paper
• Meta-Analysis of Expression of Hepatic Organic Anion–Transporting Polypeptide (OATP) Transporters in Cellular Systems Relative to Human Liver Tissue

  2015cites this paper
• Drug Transporter Protein Quantification of Immortalized Human Lung Cell Lines Derived from Tracheobronchial Epithelial Cells (Calu-3 and BEAS2-B), Bronchiolar-Alveolar Cells (NCI-H292 and NCI-H441), and Alveolar Type II-like Cells (A549) by Liquid Chromatography-Tandem Mass Spectrometry.

  2015cites this paper
• Reaction Phenotyping: Advances in the Experimental Strategies Used to Characterize the Contribution of Drug-Metabolizing Enzymes

  2015cites this paper
• PBPK modeling of irbesartan: incorporation of hepatic uptake

  2015cites this paper
• DMD059857 73..81

  2014cites this paper
• Validation of uPA/SCID Mouse with Humanized Liver as a Human Liver Model: Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases by LC-MS/MS

  2014cites this paper
• The Contribution of Human OCT1, OCT3, and CYP3A4 to Nitidine Chloride–Induced Hepatocellular Toxicity

  2014cites this paper
• Quantitative Transporter Proteomics by Liquid Chromatography with Tandem Mass Spectrometry: Addressing Methodologic Issues of Plasma Membrane Isolation and Expression-Activity Relationship

  2014cites this paper
• Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data

  2014cites this paper
• Interindividual Variability in Hepatic Organic Anion-Transporting Polypeptides and P-Glycoprotein (ABCB1) Protein Expression: Quantification by Liquid Chromatography Tandem Mass Spectroscopy and Influence of Genotype, Age, and Sex

  2014cites this paper
• A critical assessment of in vitro tissue models for ADME and drug delivery.

  2014cites this paper
• Transcriptional regulation of human UDP-glucuronosyltransferase genes

  2014cites this paper
• Quantitative Targeted Proteomics for Membrane Transporter Proteins: Method and Application

  2014cites this paper
• Optimized Methods for Targeted Peptide-Based Quantification of Human Uridine 5′-Diphosphate-Glucuronosyltransferases in Biological Specimens Using Liquid Chromatography–Tandem Mass Spectrometry

  2014cites this paper
• State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

  2014cites this paper
• Regulation of Porcine Hepatic Cytochrome P450 — Implication for Boar Taint

  2014cites this paper